Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Equity (2020 - 2025)

Biodesix (BDSX) has disclosed Return on Equity for 6 consecutive years, with 17.0% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity rose 1875.0% year-over-year to 17.0%, compared with a TTM value of 17.0% through Dec 2025, up 1875.0%, and an annual FY2025 reading of 3.87%, down 51.0% over the prior year.
  • Return on Equity was 17.0% for Q4 2025 at Biodesix, down from 136.86% in the prior quarter.
  • Across five years, Return on Equity topped out at 136.86% in Q3 2025 and bottomed at 32.47% in Q4 2023.
  • Average Return on Equity over 5 years is 10.9%, with a median of 2.13% recorded in 2025.
  • Peak annual rise in Return on Equity hit 13822bps in 2025, while the deepest fall reached -10156bps in 2025.
  • Year by year, Return on Equity stood at 2.54% in 2021, then crashed by -161bps to 6.63% in 2022, then tumbled by -390bps to 32.47% in 2023, then soared by 95bps to 1.75% in 2024, then skyrocketed by 1069bps to 17.0% in 2025.
  • Business Quant data shows Return on Equity for BDSX at 17.0% in Q4 2025, 136.86% in Q3 2025, and 6.8% in Q2 2025.